biotech funding

CAMBRIDGE, UK, April 8, 2026 Immutrin Ltd has successfully raised £65 million ($87 million) in an oversubscribed Series A...

ENCINITAS, California, United States, April 7, 2026 Kiora Pharmaceuticals, Inc. announced the successful completion of a private placement financing...

CAMBRIDGE, UK, March 31, 2026 Semarion, a University of Cambridge spin-out company, has announced the successful raise of $3.8...

CAMBRIDGE, UK, March 17, 2026 Mestag Therapeutics has announced a $40 million financing round to advance its first-in-class oncology...

Redwood City, CA – March 17, 2026 – R1 Therapeutics has officially emerged from stealth mode, announcing an oversubscribed...

HOUSTON, Texas, Dec. 10, 2025 — Moleculin Biotech, a clinical-stage company developing novel oncology drug candidates including Annamycin for...

San Francisco, CA – December 3, 2025 — Excelsior Sciences has raised $95 million in new funding to accelerate...

Cambridge, UK & Wilmington, Delaware, December 2025 — AstraZeneca has announced that the U.S. Food and Drug Administration has...

Taipei, Taiwan, December 2025 — Formosa Pharmaceuticals has announced a licensing agreement with Rxilient Biotech to commercialize clobetasol propionate...

Sydney, Australia, December 3, 2025 — Kazia Therapeutics has announced the pricing of a US $50 million private placement...